- Home
- DNLI vs IPAR Comparison
DNLI vs IPAR Comparison
Compare DNLI & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNLI | IPAR |
|---|---|---|
| Founded | 2013 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.7B |
| IPO Year | 2017 | 1995 |
Fundamental Metrics
Financial Performance| Metric | DNLI | IPAR |
|---|---|---|
| Price | $20.68 | $111.61 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 20 | 6 |
| Target Price | $36.06 | ★ $126.67 |
| AVG Volume (30 Days) | ★ 1.5M | 143.4K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 2.88% |
| EPS Growth | N/A | ★ 2.34 |
| EPS | N/A | ★ 2.31 |
| Revenue | N/A | ★ $1,317,700,000.00 |
| Revenue This Year | N/A | $0.07 |
| Revenue Next Year | $156.11 | $7.40 |
| P/E Ratio | ★ N/A | $49.86 |
| Revenue Growth | N/A | ★ 21.26 |
| 52 Week Low | $13.75 | $77.21 |
| 52 Week High | $27.30 | $129.29 |
Technical Indicators
Market Signals| Indicator | DNLI | IPAR |
|---|---|---|
| Relative Strength Index (RSI) | 42.97 | 44.37 |
| Support Level | $19.12 | $109.13 |
| Resistance Level | $22.00 | $119.40 |
| Average True Range (ATR) | 0.82 | 3.21 |
| MACD | 0.13 | 0.00 |
| Stochastic Oscillator | 60.50 | 33.68 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About IPAR Inter Parfums Inc.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.